SCHEMBL8551857

SCHEMBL8551857

CCCN1c2ncccc2C(=O)N(C)c2ccc(OS(=O)(=O)C(F)(F)F)nc21

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
BRD4 O60885 11/20 0.35
CYP1A2 P05177 1/20 0.34
DRD2 P14416 3/20 0.33
DRD1 P21728 3/20 0.33
DRD4 P21917 3/20 0.33
DRD5 P21918 3/20 0.33
DRD3 P35462 3/20 0.33
PDE4A P27815 2/20 0.33
PDE4C Q08493 2/20 0.33
PDE4D Q08499 2/20 0.33
BRDT Q58F21 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8550821 0.93 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8548965 0.84 CHRM1 (0.36) CYP1A2DRD2DRD4DRD3
SCHEMBL8548089 0.82 ALDH1A1 (0.41) CYP3A4CYP2C9CYP2C19BRD4DRD2
SCHEMBL8299628 0.77 BRD4 (0.45) CYP3A4CYP2C9CYP2C19BRD4
SCHEMBL8417093 0.77 BRD4 (0.33) BRD4DRD2DRD1DRD4DRD5
SCHEMBL8300415 0.76 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8550413 0.73 GRM2 (0.38) CYP3A4CYP2C9CYP2C19BRD4
SCHEMBL8790016 0.72 BRD4 (0.47) BRD4DRD2DRD1DRD3
SCHEMBL8301130 0.70 BRD4 (0.41) CYP3A4CYP2C9CYP2C19BRD4CYP1A2
SCHEMBL8306273 0.69 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19BRD4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5837704-A PREVENTION OR TREATMENT OF AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-11-17 US disclosed
EP-0745083-B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMA (US) 1998-05-20 EP disclosed